BORDERFREE TRADE LIMITED

Comprehensive Financial Health Assessment: Borderfree Trade Limited

1. Financial Health Score: C-

Explanation: The patient is stable but exhibits chronic underlying conditions that require ongoing management. While recent vital signs show improvement—returning to positive net assets and generating a profit in the latest year—the business suffers from a severe working capital deficiency and deep historical accumulated losses. The company is currently surviving on a financial lifeline provided by its parent company and shareholders rather than its own operational cash generation. It is recovering from a period of heavy financial bleeding, but its immune system (cash reserves relative to immediate debts) remains dangerously compromised.

2. Key Vital Signs

• Pulse (Cash Position): £437,242 The company has a reasonable cash pulse, which has strengthened from £356,820 in 2023. However, when compared to the massive £1.2 million in current liabilities, this cash reserve is akin to a patient with a steady heartbeat but low blood pressure—it is not sufficient to cover immediate demands.
• Blood Pressure (Working Capital): -£374,122 This is the most alarming vital sign. Current assets (£832,586) are far outweighed by current liabilities (£1,206,708), resulting in negative working capital. In medical terms, the business is severely fluid-overloaded with obligations; it cannot pay its immediate debts from its current assets without external intervention or converting long-term assets to cash.
• Weight & Muscle Mass (Net Assets): £81,412 After hitting a low of £38,088 in 2022, net assets have more than doubled to £81,412. This shows the patient is regaining some financial weight, but the overall mass is still very low relative to the size of the business.
• Medical History (Accumulated P&L Deficit): -£533,598 The Profit & Loss reserve shows a deep, historical deficit. This indicates years of cumulative financial bleeding (losses) that have eroded the company's retained earnings. The only thing keeping the patient's equity in positive territory is a substantial Share Premium account (£615,008), acting as a historical capital transfusion.
• Bone Density (Intangible Assets): £496,037 The vast majority of the company's asset base is tied up in development costs (intangible assets). Unlike tangible stock or property, intangibles are difficult to liquidate quickly in a crisis. If these development costs fail to generate future cash flows, they may be written off, which would severely fracture the company's balance sheet.

3. Diagnosis

Primary Condition: Chronic Liquidity Strain Masked by Parental Support Borderfree Trade Limited is suffering from acute working capital deficiency. The business owes over £1.2 million within the next 12 months but only has £832k in short-term assets to cover it. This negative working capital position is a classic symptom of financial distress.

However, the company is being kept on a form of life support: the PSC register reveals that Avask Global Compliance Ltd owns more than 75% of the company and has the right to appoint/remove directors. In practice, this means the parent company is likely funding or guaranteeing the short-term liabilities, allowing the business to continue trading despite its insolvent working capital position. The directors have explicitly stated in the accounts that they consider the going concern status to be valid, which strongly implies implicit or explicit financial backing from the parent entity.

Secondary Condition: Recovery in Progress Despite the severe liquidity issues, the 2024 financials show encouraging signs of recovery. The P&L reserve improved from -£571,341 to -£533,598, indicating that the company generated a profit of approximately £37,743 during the year. The patient has stopped bleeding and has begun to heal, transitioning from a critical state to a stable, yet highly dependent, condition.

4. Recommendations

To improve financial wellness and build resilience against future shocks, the following treatments are prescribed:

• Improve the Current Ratio (Treat the Liquidity Strain): The company must aggressively manage its short-term liabilities. Negotiate longer payment terms with creditors to slow the outflow of cash, while accelerating the collection of debtors (£395,344 is currently owed to the company) to boost cash inflows.
• Stress-Test the Intangibles (Check Bone Density): Management must rigorously assess whether the £496k in capitalized development costs is genuinely likely to generate future economic benefits. If the associated software/products are not performing, these assets must be impaired. Better to write off a weak asset now than suffer a sudden fracture later.
• Formalize Parent Support (Secure the Lifeline): Given the negative working capital, the company's ability to continue as a going concern relies heavily on the parent company. It is vital to secure a formal, legally binding letter of support (a comfort letter) from Avask Global Compliance Ltd, stating their intention to provide funding for at least 12 months. This provides assurance to auditors and creditors that the financial lifeline will not be cut.
• Reinvest Profits (Build Immunity): Now that the company has returned to profitability, resist the temptation to extract these funds. Retaining the recent £37k profit will slowly help rebuild the P&L reserve and strengthen the company's equity base, providing a thicker cushion against future operational shocks.